Oncidium foundation logo — Promote, support and accelerate the development of radiother...

Oncidium foundation

Promote, support and accelerate the development of radiotheranostics for cancer care, worldwide.

Founded 2011 Belgium Belgium 43 employees Pharmaceutical

General Information

Company Name Oncidium foundation
Founded Year 2011
Location Belgium Belgium +1
Employees 43
Industries Pharmaceutical
Social

Get notified when Oncidium foundation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Oncidium foundation

The Oncidium Foundation is dedicated to promoting, supporting, and accelerating the development of radiotheranostics for cancer care worldwide. Established in 2011, the foundation aims to advance nuclear medicine therapy through the dissemination of comprehensive information for patients. It focuses on the development of radiotherapeutics and radiotheranostics, offering a new class of drugs for patients with incurable cancers. The foundation's main priorities include raising awareness among patients and physicians, investing in research and scholarships, financing the development of new radiopharmaceuticals for therapy, supporting clinical best practices, and enhancing patient access. As an organization operating in the pharmaceutical industry, Oncidium Foundation plays a crucial role in driving advancements in cancer treatment. Although specific headquarters information and recent investment details are not available at this time, the foundation's commitment to promoting innovative cancer care solutions positions it as a noteworthy entity for potential venture capital interest. The Foundation's focus on pioneering radiotheranostics and its impact on addressing unmet medical needs in cancer care make it a compelling prospect for investors looking to support groundbreaking advances in the pharmaceutical and oncology sectors.

Taxonomy: radiotheranostics, cancer care, nuclear medicine therapy, radiopharmaceuticals development, oncology treatment, patient awareness, physician awareness, research investment, scholarship, clinical best practices, patient access, radiopharmaceuticals promotion, cancer patient support

No funding data available for Oncidium foundation yet.

Get notified when Oncidium foundation raises funding

Oncidium foundation Alternatives & Competitors

Oncidium foundation vs

Increasing Patient Access to Particle Therapy

10 employees
Oncidium foundation vs
RayzeBio
RayzeBio United States

Targeted innovative radiopharmaceuticals for cancer

Acquired
258 employees
Biotechnology, Health Care
Oncidium foundation vs
Entia
Entia United Kingdom

Unlocking the full potential of cancer therapy with at-home blood monitoring

Series A
32 employees
Biotechnology, Health Care

FAQ About Oncidium foundation

Promote, support and accelerate the development of radiotheranostics for cancer care, worldwide.
Oncidium foundation was founded in 2011.
Oncidium foundation is headquartered in Belgium.
Oncidium foundation operates in the following industries: Pharmaceutical.
Oncidium foundation has approximately 43 employees.
Top alternatives and competitors to Oncidium foundation include The National Association for Proton Therapy, RayzeBio, Entia, Cvergenx, Pentixapharm AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oncidium foundation and The National Association for Proton Therapy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Oncidium foundation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy